Chronic kidney disease–associated pruritus (CKD-aP), previously referred to as uremic pruritus, is itching due to kidney disease that can vary in clinical presentation from mild to severe and can affect patient quality of life and survival [1, 2–3]. CKD-aP can be recurrent and sometimes persistent...
End-stage renal illness severely affects health care systems and is prevalent worldwide [1]. One of the primary options for end-stage renal illness, which affects approximately 11% of dialysis patients overall, is continuous ambulatory peritoneal dialysis (CAPD) [2]. Cardiovascular complications represent...
End-stage kidney disease (ESKD) is a critical global health issue, imposing a significant burden on healthcare systems [1, 2]. From 2000 to 2019, the prevalence rate of ESKD among Asians increased by 149.5% [3]. Hemodialysis (HD) and peritoneal dialysis (PD) are the two primary treatment modalities for...
As a significant global public health issue, chronic kidney disease (CKD) affects millions of people worldwide [1, 2]. The progression of CKD can result in a gradual deterioration of renal function and ultimately come to end-stage renal disease (ESKD), requiring life-sustaining peritoneal dialysis or...
Chronic Kidney Disease (CKD) is a worldwide public health problem that has become a leading cause of death, with an estimated prevalence of 9.1% [1]. The global incidence of end-stage kidney disease (ESKD) is 146 individuals per million population (pmp) per year. The highest incidence of ESKD can be...